Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00276575
Recruitment Status : Completed
First Posted : January 13, 2006
Last Update Posted : November 19, 2014
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Herbert Hurwitz, MD, Duke University